[Taktivin treatment of immunologic disorders in patients with nonspecific ulcerative colitis].
作者信息
Shafer N P
出版信息
Klin Med (Mosk). 1993;71(3):45-7.
PMID:8015217
Abstract
Nonspecific ulcerative colitis (NSUC) varying in severity was treated by conventional methods (49 patients) against combined treatment including tactivin (93 patients). All the patients were examined immunologically at admission and in the course of the treatment. The drug produced a positive effect on immunological status, treatment effectiveness rose, NSUC exacerbations rapidly attenuated.
摘要
相似文献
1
[Taktivin treatment of immunologic disorders in patients with nonspecific ulcerative colitis].
Klin Med (Mosk). 1993;71(3):45-7.
2
[Comparison of the efficacy of topical and subcutaneous administration of tactivin for correcting secondary immunodeficiencies of young children].
Biull Eksp Biol Med. 1994 Nov;118(11):496-8.
3
[Use of T-activin and thymalin in the treatment of ophthalmic herpes].
Vestn Oftalmol. 1991 Sep-Oct;107(5):51-4.
4
[The use of tactivin for treating patients with IHD].
Ter Arkh. 1995;67(9):24-7.
5
[Use of the Gepon immunomodulator for ulcerative colitis treatment].
Eksp Klin Gastroenterol. 2005(1):14-9, 106.
6
7
[Use of taktivin and levamisole in the combined treatment of diffuse toxic goiter].
Sov Med. 1987(12):32-5.
8
[Comparative study of the effectiveness of immunomodulating preparations in combined therapy of chronic obstructive bronchitis].
Klin Med (Mosk). 1995;73(4):88-90.
9
[Effectiveness of immunostimulants in nonspecific ulcerative colitis].
Sov Med. 1990(4):17-9.
10
[T-cell immunity and immunomodulators in the comprehensive treatment of diffuse toxic goiter].
Ross Med Zh. 1992(5-12):19-24.
Zotero 插件